Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.
3 reports, 3 independent
Updated Aug 9
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts at Wells Fargo raised price targets for Medtronic, while UBS analysts provided bullish notes on the company's prospects.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.UBS upgraded Medtronic to Buy; BTIG noted MedTech stabilization.1 source
Wells Fargo and UBS analysts issued bullish ratings on Medtronic on August 21, 2025.1 source
Keep exploring
The entities involved
-
Medtronic plc
medical device company
Nothing else this week.
-
Wells Fargo
American multinational banking and financial services company
-
UBS
Swiss multinational investment bank and financial services company
Related events
- Wells Fargo raised a price target to $56, while Goldman Sachs research highlighted risks associated with AI agents.
- UBS raised its price target for Micron Technology.
- UBS raised its price target after discussing demand trends with ServiceNow partners.
- Wells Fargo raised its price target for Meta on October 7, 2026.
Coverage
Newest first; wire copies grouped- yahoo.com
- insidermonkey.com
- Motley FoolWhy Medtronic Stock Raced Higher Today Investors traded out of the company the previous day following its latest earnings release. The stock came roaring back on Hump Day, however. 10 stocks we like